6LD-24852-19877
3 vaccinations
3 coded responses
22 check-ins
3 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 840 / UT
- Registered
- 2021-01-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-16
Registered in v-safe
-
2021-01-16
Dose 1 — Pfizer-BioNTech
-
2021-01-16
Survey response — day 0, dose 1MedDRA: Pruritus — Feeling: Fair · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: ItchinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-16
Report sent to call center — day 0, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-17
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to workAdult check-in
- 2021-01-17
-
2021-01-18
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to workAdult check-in
- 2021-01-18
-
2021-01-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-21
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-01-22
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-23
Health check-in — day 7, dose 1Feeling: Fair · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-20
Dose 2 — Pfizer-BioNTech
- 2021-02-20
-
2021-02-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-02-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-23
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Chills, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-27
Health check-in — day 7, dose 2Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-06
- 2021-03-13
- 2021-03-29
- 2021-04-03
- 2021-05-22
-
2021-08-21
Survey response — 6 months, dose 2MedDRA: Ageusia, Anosmia, Asthenia, Cough — Feeling: Poor · Be unable to work or attend schoolFree text: No energy, loss of taste and smell, bad coughMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-11-19
Dose 3 — Pfizer-BioNTech
-
2022-02-20
Survey response — 12 months, dose 2MedDRA: Office visit, Pneumonia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Pneumonia · Healthcare visit (other): 2 office visitsMedDRA releases: 2024-11 · check-in free text available
-
2022-02-20
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2022-02-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-16 | Pfizer-BioNTech | |
| 2 | 2021-02-20 | Pfizer-BioNTech | |
| 3 | 2021-11-19 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-16 | priority 2/3 | |
| 2021-01-17 | priority 2/3 | |
| 2021-01-18 | priority 2/3 | |
| 2022-02-20 | Unsuccessful |
Free text
Release 2 — day 0, dose 1
Systemic reaction (other): Itchiness
Release 9 — 6 months, dose 2
Symptoms: No energy, loss of taste and smell, bad cough
Release 11 — 12 months, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Ageusia | ✓ | · | ✓ |
| SD | Anosmia | ✓ | · | ✓ |
| SD | Asthenia | ✓ | · | ✓ |
| SD | Cough | ✓ | · | ✓ |
| SD | Pneumonia | · | · | ✓ |
| SRO | Pruritus | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release